These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20609221)
1. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Sharma P; Kumar S; Kundu GC Mol Cancer; 2010 Jul; 9():178. PubMed ID: 20609221 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. Yamaguchi K; Lantowski A; Dannenberg AJ; Subbaramaiah K J Biol Chem; 2005 Sep; 280(38):32569-77. PubMed ID: 15994313 [TBL] [Abstract][Full Text] [Related]
3. Trichostatin A activates the osteopontin gene promoter through AP1 site. Sakata R; Minami S; Sowa Y; Yoshida M; Tamaki T Biochem Biophys Res Commun; 2004 Mar; 315(4):959-63. PubMed ID: 14985105 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy. Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400 [TBL] [Abstract][Full Text] [Related]
5. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. Zhang Y; Dufau ML J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390 [TBL] [Abstract][Full Text] [Related]
6. Effects of trichostatin A on neuronal mu-opioid receptor gene expression. Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606 [TBL] [Abstract][Full Text] [Related]
7. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells. Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H Oncology; 2004; 66(6):481-91. PubMed ID: 15452378 [TBL] [Abstract][Full Text] [Related]
8. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
9. Induction of ID1 expression and apoptosis by the histone deacetylase inhibitor (trichostatin A) in human acute myeloid leukaemic cells. Yu WP; Scott SA; Dong WF Cell Prolif; 2008 Feb; 41(1):86-97. PubMed ID: 18211287 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. Lee KJ; Lee KY; Lee YM Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132 [TBL] [Abstract][Full Text] [Related]
11. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Zhao S; Venkatasubbarao K; Li S; Freeman JW Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289 [TBL] [Abstract][Full Text] [Related]
12. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884 [TBL] [Abstract][Full Text] [Related]
13. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. Choi HS; Lee JH; Park JG; Lee YI Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. Pan L; Lu J; Wang X; Han L; Zhang Y; Han S; Huang B Cancer; 2007 Apr; 109(8):1676-88. PubMed ID: 17330857 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. Law AY; Lai KP; Lui WC; Wan HT; Wong CK Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885 [TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. Wilson MA; Ricci AR; Deroo BJ; Archer TK J Biol Chem; 2002 Apr; 277(17):15171-81. PubMed ID: 11821430 [TBL] [Abstract][Full Text] [Related]
18. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. Li H; Wu X Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507 [TBL] [Abstract][Full Text] [Related]